Application of peste des petits ruminants virus resistant sheep Rab7 gene
By overexpressing the Rab7 gene in sheep somatic cells or interfering with its expression, the problem of regulating the replication level of ruminants viruses is solved, inhibiting PPRV and obtaining high-titer viruses is achieved, and new methods for research and vaccine preparation are provided. .
Patent Information
- Application Number
- CN202410930441.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-11
- Publication Date
- 2024-11-08
AI Technical Summary
The prior art has failed to effectively explore the effect of the goat Rab7 gene on replication levels after infection with the PPRV virus and its potential value in the preparation of highly efficient viral amplified cells.
By constructing a Rab7 gene overexpression vector in goat somatic cells, it inhibits the replication of PPRV, and obtains a high titer PPRV virus by interfering with Rab7 gene expression to study pathogenic mechanisms and vaccine preparation.
It significantly inhibited the replication level of PPRV, provided antiviral activity, and provided efficient virus amplification for the pathogenic mechanism of the ruminant virus and vaccine preparation, opening up new ideas for prevention and control.
Smart Images

Figure BDA0004939478810000061 
Figure BDA0004939478810000062 
Figure BDA0004939478810000071
Abstract
Description
Technical Field
[0001] The invention belongs to the field of animal genetic engineering and relates to an application of sheep Rab7 gene in resisting peste des petits ruminants virus. Background Art
[0002] Peste des petits ruminants (PPR), commonly known as sheep plague, is an acute viral infectious disease caused by Peste des Petits Ruminants virus (PPRV) of the Morbillivirus genus of the Paramyxoviridae family infecting small ruminants such as goats and sheep. PPR is mainly manifested as acute gastritis, bronchopneumonia, enteritis and abortion in pregnant ewes. At present, the disease has become an endemic epidemic, directly restricting the development of the sheep industry.
[0003] Studies have shown that PPRV-infected cells can produce exosomes carrying viral genomes, which can cause PPRV infection through intercellular transmission of exosomes (see "PPRV-Induced Autophagy Facilitates Infectious Virus Transmission by the Exosomal Pathway"). Combined with other studies, it is known that exosomes from PPRV infection sources can increase the PPRV infection level of receiving cells (see "MicroRNA-218 Regulates Signaling Lymphocyte Activation Molecular (SLAM) Mediated Peste des Petits Ruminants Virus Infectivity in Goat Peripheral Blood Mononuclear Cells" and "Extracellular vesicles derived from PPRV infected cells enhance signaling lymphocyte activation molecule (SLAM) receptor expression and facilitate virus infection").
[0004] Rab7 is located in early endosomes (EEs) and late endosomes (LEs) / multivesicular bodies (MVBs), also known as Rab7a, and has been shown to be an important component of endocytic transport and lysosomal degradation. Studies have shown that Rab7 can regulate the transport process of early endosomes, while it has been reported that Rab7 mainly affects the maturation of late endosomes to lysosomes, thereby affecting the generation and release of exosomes.
[0005] Although previous studies have shown that PPRV infection can affect the expression level of Rab7 (see "Study on the role of IFITM in the early stage of peste des petits ruminants virus (PPRV) infection"), since PPRV completes entry (such as 1.5 hours) and causes the first wave of autophagy 1 to 3 hours after infecting cells (see "Peste des Petits Ruminants Virus Enters Caprine Endometrial Epithelial Cells via the Caveolae-Mediated Endocytosis Pathway" and "Autophagy induction by the pathogen receptor NECTIN4 and sustained autophagy contribute to peste des petits ruminants virus infectivity"), this study actually explored the changes in Rab7 expression levels during the PPRV invasion process (2 hours after PPRV infection of goat endometrial epithelial cells) and the effect of regulating the Rab7 gene on PPRV entry. It is still impossible to determine the effect of the Rab7 gene on the replication level after PPRV infection, nor has it revealed the potential value of the Rab7 gene in preparing efficient virus amplification cells. Summary of the invention
[0006] The purpose of the present invention is to provide an application of sheep Rab7 gene against peste des petits ruminants virus.
[0007] In order to achieve the above object, the present invention adopts the following technical solutions:
[0008] The invention discloses an application of a Rab7 gene overexpression vector in the preparation of a drug for resisting peste des petits ruminants virus. The expression vector comprises a sheep Rab7 gene.
[0009] Preferably, the sheep Rab7 gene is from goats.
[0010] Preferably, the nucleotide sequence of the sheep Rab7 gene is as shown in SEQ.ID.NO.1, which can be used to achieve eukaryotic expression (such as expression in sheep somatic cells).
[0011] Preferably, the expression vector is prepared by inserting the sheep Rab7 gene into the pcDNA3.1(+) vector.
[0012] Preferably, the method for preparing the expression vector comprises the following steps:
[0013] 1) Taking sheep Rab7 gene as the target gene, amplifying the target gene and performing a ligation reaction with the expression vector backbone to obtain a ligation product;
[0014] 2) The ligation product is transformed into a host bacterium for resistance screening, and the single clone obtained by screening is cultured after identification by colony PCR. After culture, the plasmid is extracted for restriction digestion and sequencing verification, and it is verified to be the correct plasmid, i.e., the Rab7 gene overexpression vector.
[0015] Preferably, in step 1, the nucleotide sequence of the target gene is as shown in SEQ.ID.NO.1.
[0016] Preferably, in step 1, the primers used for amplification are shown as SEQ.ID.NO.2 and SEQ.ID.NO.3.
[0017] Preferably, in step 1, the expression vector backbone is specifically prepared by linearizing the pcDNA3.1(+) vector by NotⅠ / XbaI double digestion, and the pcDNA3.1(+) linearized vector fragment is recovered and connected to the target gene to construct a Rab7 gene overexpression vector (such as recombinant plasmid pcDNA3.1-Rab7).
[0018] Preferably, the expression vector (ie, overexpressing the sheep Rab7 gene) inhibits the replication of Peste des Petits Ruminants virus.
[0019] Preferably, the expression vector (i.e., overexpressing the sheep Rab7 gene) achieves antiviral efficacy by inhibiting the increase in viral replication levels in cells during the infection and replication cycle of the peste des petits ruminants virus (9 to 12 hours after infection).
[0020] A method for preparing high-titer peste des petits ruminants virus comprises the following steps:
[0021] The siRNA interfering with the expression of the sheep Rab7 gene was transfected into the host sheep cells to obtain the interfering cells; the interfering cells obtained by infecting the peste des petits ruminants virus were cultured, and the virus titer in the cell culture supernatant was significantly higher than the virus titer in the cell culture supernatant obtained after normal infection (i.e., infection of the host sheep cells without knocking down the Rab7 gene) from 9 hours after infection; after the culture was completed (i.e., culture ≥9 hours), the cell culture supernatant was separated to obtain the high-titer peste des petits ruminants virus.
[0022] Preferably, the nucleotide sequence of the siRNA is as follows:
[0023] sense: 5'-CAACUAAUUUCCUGAACCU-3'
[0024] antisense: 5'-AGGUUCAGGAAAUUCGUUG-3'.
[0025] Preferably, the peste des petits ruminants virus is selected from the peste des petits ruminants virus vaccine attenuated strain N75-1.
[0026] Preferably, the host sheep cells are goat endometrial epithelial cells.
[0027] The invention discloses a virus amplification cell, which is a host sheep cell infected with peste des petits ruminants virus and in which the expression of Rab7 gene is knocked down.
[0028] Preferably, the cells are constructed by infecting the peste des petits ruminants virus after transfecting the above-mentioned siRNA that interferes with the expression of the sheep Rab7 gene. After culturing the constructed cells, a high titer of peste des petits ruminants virus can be obtained, which is helpful to better study the pathogenic mechanism of peste des petits ruminants virus and more efficiently amplify peste des petits ruminants virus vaccine strains.
[0029] The beneficial effects of the present invention are embodied in:
[0030] The present invention is based on the dynamic changes of the replication level of the PPR virus and the expression level of Rab7 in host sheep cells (such as goat endometrial epithelial cells) infected with the PPR virus (such as the vaccine strain N75-1) at different stages, and for the first time identifies the sheep Rab7 gene as a disease-resistant gene against PPR, and reveals that the Rab7 protein level is negatively correlated with the replication level of the PPR virus. The antiviral activity can be achieved by overexpressing the Rab7 gene in sheep somatic cells, and by interfering with the Rab7 gene in sheep somatic cells, rapid replication of the PPR virus after infection and high-titer PPR virus can be achieved, thereby not only providing efficient virus amplification cells for the study of the pathogenic mechanism of the PPR virus and the preparation of inactivated vaccines and attenuated vaccines for the PPR virus, but also providing new ideas for the prevention and control of PPR. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 The results show the dynamic changes of Rab7 expression level in goat EECs after PPRV infection; A shows the expression level of Rab7 protein and PPRV replication (PPRV-N protein expression) level detected by Western blot at different periods after PPRV infection (β-actin is the internal reference); B shows the level of Rab7 mRNA in goat EECs detected by real-time fluorescence quantitative PCR at different periods after PPRV infection (** indicates p<0.01 for the expression level of Rab7 in EECs not infected with PPRV, ns indicates p>0.05 for the expression level of Rab7 in EECs not infected with PPRV).
[0032] Figure 2 The results of goat Rab7 gene cloning and overexpression vector identification; wherein: A is the PCR product identification of goat Rab7 gene (lane M is DL2000 plus DNA Marker, lane 1 is the PCR product of goat Rab7 gene); B is the restriction enzyme digestion identification of pcDNA3.1-Rab7 (lane M is DL5000 plus DNA Marker, lane 1 is NotⅠ and Xba I double enzyme digestion).
[0033] Figure 3 This is the identification result of protein overexpression in goat Rab7 gene overexpression vector cells: pcDNA3.1 is the blank vector negative control of the overexpression group, the overexpression group is the goat Rab7 gene overexpression vector pcDNA3.1-Rab7 constructed by transfection, and β-actin is the internal reference.
[0034] Figure 4 The results of the effect of overexpression of goat Rab7 gene on PPRV replication; A is the Western blot detection of PPRV replication (PPRV-N protein expression) level in goat EECs (MOCK is untreated group cells, PPRV is PPRV-infected group cells, pcDNA3.1 is blank vector-transfected group cells, pcDNA3.1-Rab7 is overexpressed group cells, pcDNA3.1+PPRV is blank vector-transfected group cells infected with PPRV, pcDNA3.1-Rab7+PPRV (or pcDNA-Rab7+PPRV) is overexpressed group cells infected with PPRV, β-actin is the internal reference); B is the detection of virus half tissue culture infection dose (TCID) in the culture supernatant of goat EECs. 50 ), and ** represents the TCID of virus in the culture supernatant relative to cells infected with PPRV alone 50 Levels p < 0.01, ns represent the virus TCID in the culture supernatant of cells infected with PPRV only 50 Level p>0.05; C is the co-localization level of PPRV-N protein and Rab7 protein in pcDNA3.1-Rab7+PPRV group cells observed by indirect immunofluorescence (IFA) (** indicates the co-localization level of PPRV-N protein and Rab7 protein relative to that of cells infected with PPRV only group p<0.01, ns indicates the co-localization level of PPRV-N protein and Rab7 protein relative to that of cells infected with PPRV only group p>0.05).
[0035] Figure 5This is the identification result of the interfering RNA of goat Rab7 gene: NC is the negative control siRNA, siRab7 is the interfering RNA of transfected goat Rab7 gene, and β-actin is the internal reference.
[0036] Figure 6 The results of interfering with goat Rab7 gene expression on PPRV replication; A is Western blot detection of PPRV replication (PPRV-N protein expression) level in goat EECs (MOCK is untreated group cells, PPRV is PPRV-infected group cells, NC is negative control siRNA-transfected group cells, siRab7 is Rab7 gene-interfering RNA-transfected group cells, NC+PPRV is negative control siRNA-transfected group cells and then infected with PPRV group cells, siRab7+PPRV is Rab7 gene-interfering RNA-transfected group cells and then infected with PPRV group cells, β-actin is the internal reference); B is the detection of virus TCID in goat EECs culture supernatant 50 (** indicates the TCID of virus in the culture supernatant relative to cells infected with PPRV alone 50 Level p < 0.01, ns represents the virus TCID in the culture supernatant of cells infected with PPRV only 50 Level p>0.05); C is the co-localization level of PPRV-N protein and Rab7 protein in the cells of siRab7+PPRV group observed by indirect immunofluorescence (IFA) (** indicates the co-localization level of PPRV-N protein and Rab7 protein relative to the cells of PPRV only infected group p<0.01, ns indicates the co-localization level of PPRV-N protein and Rab7 protein relative to the cells of PPRV only infected group p>0.05). DETAILED DESCRIPTION
[0037] The present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. The embodiments are only used to explain the present invention, but not to limit the scope of protection of the present invention.
[0038] Different from the previous studies focusing on the early stage of viral infection, the present invention deeply observed the dynamic changes of Rab7 protein expression levels in goat somatic cells during PPRV infection at different stages, and found that PPRV infection can cause Rab7 expression levels to show more complex changes (as the infection time increases, it rises rapidly in the entry stage and then drops sharply, and then continues to rise to a higher level). Even so, in order to explore whether the Rab7 gene plays a role in the PPRV replication process and what role it plays, the Rab7 gene was overexpressed and knocked down to construct goat Rab7 gene overexpression cells and interfere with goat Rab7 gene expression cells, and the changes in the viral replication level were detected after the two constructed cells were infected with PPRV. It was found that overexpressing goat Rab7 gene can significantly inhibit the replication level of PPRV, and it was found that the interfering RNA of goat Rab7 gene can be used to achieve high-speed replication of PPRV in host cells. The specific experiments and results are described as follows.
[0039] (I) Preparation of biological materials and experimental reagents
[0040] Goat endometrial epithelial cells (EECs) were donated by Professor Jin Yaping from the College of Veterinary Medicine of Northwest Agriculture and Forestry University (September 2014); Rab7 antibody (rabbit source) was purchased from Abways Technology Biotechnology Co., Ltd., PPRV-N monoclonal antibody (mouse source) was provided by the Chinese Animal Health and Epidemiology Center (Qingdao, China), and PPRV was the attenuated strain of peste des petits ruminants virus vaccine N75-1 (PPRV Nigeria) amplified and preserved in our laboratory. 75-1); horseradish peroxide (HRP)-labeled goat anti-mouse IgG antibody and horseradish peroxide (HRP)-labeled goat anti-rabbit IgG antibody were purchased from Shanghai Diyi Biotechnology Co., Ltd.; mRNA reverse transcription and quantification kits were purchased from Beijing Quanshijin Company, and qPCR kits were purchased from Beijing Quanshijin Company; PVDF membranes were purchased from Immobilon Biological Company; ECL colorimetric solution was purchased from Beijing Dinning Biotechnology Co., Ltd.; pcDNA3.1(+) was purchased from Thermo Fisher Scientific Inc., plasmid extraction kits were purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd., NotⅠ enzyme and XbaI enzyme were purchased from TaKaRa Company, and Escherichia coli DH5ɑ competent cells were purchased from Beijing Qingke Biotechnology Co., Ltd.; TurboFect was purchased from Thermo Fisher Scientific Inc.; Cy3-labeled goat anti-rabbit fluorescent secondary antibody was purchased from Shanghai Shenggong Biotechnology Co., Ltd., and Alexa Fluor 488-labeled goat anti-mouse fluorescent secondary antibody was purchased from Yisheng Biotechnology Co., Ltd.; all other conventional reagents were of analytical grade.
[0041] (II) Dynamic changes of Rab7 expression levels in cells infected with PPRV at different stages
[0042] Goat EECs in the logarithmic growth phase were digested with trypsin and mixed by pipetting with DME / F-12 containing 10% FBS. The volume was adjusted to 6×10 after counting. 5 / well in a 12-well plate; when the cells in the wells grew to about 80%, the old culture medium was discarded, and PPRV virus solution was added to each well to an MOI of 5, and the wells were placed in a 37°C, 5% CO2 incubator. The virus solution was discarded at 0h (i.e., uninfected), 1.5h, 3h, 6h, 9h, 12h, and 24h after infection, and the wells were washed once with PBS buffer.
[0043] 100 μL tissue lysis buffer (containing protease inhibitor PMSF) was added to each well, and the mixture of cells and lysis buffer was collected and placed in a 1.5 mL centrifuge tube to mark the treatment group; the collected samples were lysed at 4°C for 15 min, centrifuged at 4°C and 12000 rpm for 10 min, the supernatant was aspirated into a new 1.5 mL centrifuge tube, 25 μL protein tracer loading buffer (5× denaturation, reduction) was added, vortexed for a few seconds to mix, and placed in a 100°C water bath for 10 min. The prepared protein samples were detected by Western blot (SDS-PAGE, transferred to PVDF membrane, blocked, and protein expression was detected with antibodies) to measure the Rab7 protein expression level and PPRV replication level. Western blot detection results showed that the Rab7 expression level was inhibited in the early stage of PPRV infection (such as 3 hours after infection), and the Rab7 expression level gradually increased with the increase of infection time, but it was still lower than the Rab7 level in uninfected cells (such as 9 to 12 hours after infection). After 24 hours of infection, the Rab7 expression level increased to a level higher than the Rab7 level in uninfected cells ( Figure 1 A).
[0044] At the same time, the total RNA of the cells was extracted by TRIZOL precipitation method, and then the extracted total RNA of the cells was reverse transcribed into cDNA: specifically, the reverse transcription reaction system (Table 1) was placed in a PCR instrument and incubated at 42°C for 30 minutes, and then heated at 85°C for 5 seconds to inactivate the reverse transcriptase. The cDNA obtained by reverse transcription was used as a template, and the intracellular Rab7 mRNA level was detected using qPCR primers: specifically, the qPCR reaction system (Table 2) was placed in a PCR instrument for pre-denaturation at 94°C for 30 seconds and then subjected to (94°C for 5 seconds, 58°C for 15 seconds, and 72°C for 10 seconds) × 40 cycles of reaction. The results of real-time fluorescence quantitative PCR showed that the Rab7 mRNA level was inhibited in the early stage of PPRV infection (such as 3 hours after infection), and the Rab7 mRNA level gradually increased with the increase of infection time, but it was still lower than the Rab7 mRNA level in uninfected cells (such as 9 to 12 hours after infection). After 24 hours of infection, the Rab7 mRNA level increased to a level higher than the Rab7 mRNA level in uninfected cells ( Figure 1 B).
[0045] Table 1. Reverse transcription cDNA synthesis system
[0046]
[0047] Table 2. qPCR reaction system
[0048]
[0049]
[0050] Note: Primer sequences are shown in Table 3.
[0051] Table 3. qRT-PCR primer sequence list
[0052]
[0053] (III) Cloning of goat Rab7 gene and construction of eukaryotic expression vector
[0054] According to the sequence of goat Rab7 gene in the GenBank database (GenBank: JQ417405.1), primers for amplifying the full length of the gene CDS (see the following SEQ.ID.NO.1 for details) were designed.
[0055] Table 4. Goat Rab7 gene sequence
[0056]
[0057] The primer sequences designed according to SEQ.ID.NO.1 are as follows:
[0058] Upstream primer Rab7-F, SEQ.ID.NO.2: (The italic part indicates the Not I restriction site);
[0059] Downstream primer Rab7-R, ie, SEQ.ID.NO.3: (The italic part indicates the Xba I restriction site).
[0060] The total RNA of goat EECs was extracted by TRIZOL precipitation method, and then the extracted total cell RNA was reverse transcribed into cDNA: specifically, the reverse transcription reaction system (Table 1) was placed in a PCR instrument and incubated at 42°C for 30 minutes, and then heated at 85°C for 5 seconds to inactivate the reverse transcriptase. The cDNA obtained by reverse transcription was used as a template, and the primers Rab7-F and Rab7-R were used to PCR amplify the goat Rab7 gene sequence (amplification reaction system is shown in Table 5, PCR reaction program: 95°C pre-denaturation for 5 minutes; 95°C denaturation for 30 seconds, 68°C annealing for 30 seconds, 72°C extension for 1 minute, running for 35 cycles; 72°C for 10 minutes).
[0061] The PCR product (identification results see Figure 2 A) and pcDNA3.1(+) were double-digested with restriction endonucleases Not I and XbaI, respectively (the digestion reaction system is shown in Table 6). After electrophoresis, the target gene and vector backbone were recovered from the gel and connected according to the connection system shown in Table 7. The connection product was transformed into Escherichia coli DH5ɑ competent cells by heat shock method. After culturing at 37°C for 1 hour, a small amount of liquid was drawn and applied to the surface of LB solid culture medium with ampicillin resistance, and cultured at 37°C for 16 hours. Single clones were picked for colony PCR identification, and positive bacteria were expanded and cultured in LB liquid culture medium with ampicillin resistance, and then plasmids were extracted for digestion identification. The results are shown in Figure 2 As shown in B, after correct identification, it was sent to a biological company for sequencing, and the plasmid with correct sequencing was named to obtain the Rab7 gene overexpression vector pcDNA3.1-Rab7.
[0062] Table 5. PCR reaction system
[0063]
[0064] Table 6. Enzyme digestion system
[0065]
[0066] Table 7. Connection system
[0067]
[0068] (IV) Identification results of protein overexpression in goat Rab7 gene overexpression vector cells
[0069] After trypsin digestion, goat EECs were mixed with DME / F-12 medium containing 10% FBS and inoculated into 12-well culture plates. The cell density reached 70% to 90% for plasmid transfection. Before transfection, the old culture medium was discarded, washed once with PBS buffer, and 500μL of DME / F-12 medium containing 2% FBS was added; 4μg pcDNA3.1-Rab7 plasmid, 4μL TurboFect transfection reagent and 100μL serum-free Opti-MEMⅠ medium were added to a 1.5mL RNase-free centrifuge tube, mixed evenly and allowed to stand for 25min to prepare a transfection complex, which was added dropwise to the culture wells. At the same time, pcDNA3.1(+) was transfected as a negative control in this way; the culture plate was placed in a 37℃, 5% CO2 incubator for 24h. Protein samples were prepared using tissue lysate according to the method in (ii) to detect the overexpression effect of pcDNA3.1-Rab7. Western blot results showed that the expression level of Rab7 protein was significantly increased in cells transfected with pcDNA3.1-Rab7 plasmid ( Figure 3 5. Effect of overexpression of goat Rab7 gene on PPRV replication
[0070] The pcDNA3.1-Rab7 plasmid was transfected according to the method in (IV), and the cell groups that were not transfected and transfected with blank plasmid (i.e., pcDNA3.1(+)) were set up at the same time. After the transfection was completed, the culture plate was placed in a 37°C, 5% CO2 incubator for 24 hours, and then infected with PPRV (MOI=5). At the same time, the corresponding three groups that were not infected with PPRV were retained. After 9 hours, the PPRV replication level was detected, and the virus TCID in the cell culture supernatant was detected. 50 And perform IFA testing.
[0071] Protein samples were prepared according to the method in (II). Western blot results showed that compared with cells infected with PPRV alone, the viral replication level in cells infected with PPRV after transfection with the constructed overexpression vector was significantly inhibited, while the viral replication level in cells infected with PPRV after transfection with the blank plasmid did not change significantly ( Figure 4 A).
[0072] Resuspend the Vero cells in the logarithmic growth phase and adjust the cell concentration to 2×10 4 / mL, evenly inoculated into 96-well plates, and when the cell density reached about 80%, gradient dilution (10 1 ~10 10The cell culture supernatant of the pcDNA3.1-Rab7+PPRV group was added to a 96-well plate, and 8 replicate wells were inoculated for each gradient concentration for parallel replication. At the same time, an equal amount of maintenance solution was added to the blank control wells. The CPE was observed every day, and the viral titer of the amplified PPRV (i.e., TCID 50 ), and the virus titer in the cell culture supernatant of the PPRV-only infection group and the pcDNA3.1+PPRV group was detected as a control. The results showed that compared with the cells infected with PPRV alone, overexpression of the Rab7 gene followed by infection with PPRV could significantly reduce the virus titer in the cell culture supernatant, while there was no significant change in the virus titer in the group infected with blank plasmid and then infected with PPRV ( Figure 4 B).
[0073] The cells of the pcDNA3.1-Rab7+PPRV group, MOCK group, PPRV group and pcDNA3.1+PPRV group were fixed with 4% paraformaldehyde, and then permeabilized with 0.5% Triton X-100 for 10 minutes at room temperature, and then blocked with 5% BSA for 1.5 hours; 1% BSA was used as an antibody diluent, Rab7 antibody was added, incubated at 4°C overnight, and the cells were washed with PBST solution; 1% BSA was used as an antibody diluent, PPRV-N antibody was added, incubated at 4°C for 8 hours, and the cells were washed with PBST solution; Cy3-labeled goat anti-rabbit fluorescent secondary antibody and Alexa Fluor 488-labeled goat anti-mouse fluorescent secondary antibody were added accordingly, and incubated at 37°C in the dark for 1.5 hours; Hoechest33342 was added to stain the nucleus for 10 minutes; the fluorescence intensity of PPRV-N protein and Rab7 protein was observed under a laser confocal microscope. The results of IFA detection of the fluorescence intensity of PPRV-N protein and Rab7 protein in cells are shown in the figure. Figure 4 As shown in C, compared with the cells infected with PPRV only, the PPRV-N protein content indicated by green fluorescence in the cells of the PPRV group after transfection with the constructed overexpression vector was significantly reduced, and the Rab7 protein content indicated by red fluorescence in this group of cells was significantly increased, while there was no obvious change in the green fluorescence intensity and red fluorescence intensity in the PPRV group after transfection with the blank plasmid.
[0074] These results indicate that the intracellular PPRV replication level decreases with Rab7 gene overexpression.
[0075] (VI) Identification of interfering RNA of goat Rab7 gene
[0076] First, interfering RNA (siRNA) targeting goat Rab7 gene expression was designed. Then, negative control siRNA (NC) and siRab7 were transfected into goat EECs cells using TurboFect transfection reagent: EECs were cultured in a 12-well cell culture plate, and transfection was performed when the cell density reached 70% to 90%. The final concentration of NC or siRab7 was 50 nM, and the Turbofect transfection reagent was 3 μL, wherein siRab7 was siRNA with the following sequence:
[0077] sense: 5'-CAACUAAUUUCCUGAACCU-3' (ie SEQ.ID.NO.4)
[0078] Antisense: 5'-AGGUUCAGGAAAUUCGUUG-3' (ie SEQ.ID.NO.5).
[0079] 24 hours after transfection, the protein samples were prepared using tissue lysis buffer according to the method in (II). The results of Western blot detection of the interference effect of siRab7 showed that the expression level of Rab7 protein was significantly reduced in cells transfected with siRab7 ( Figure 5 ).
[0080] (VII) Effect of interfering with goat Rab7 gene expression on PPRV replication
[0081] Transfect siRab7 according to the method in (VI), and set up untransfected and transfected NC cell groups. After transfection, the culture plate was placed in a 37°C, 5% CO2 incubator for culture. After 24 hours, PPRV was infected again (MOI = 5). At the same time, the corresponding three groups that were not infected with PPRV were retained. After 9 hours, the PPRV replication level was detected, and the virus TCID in the cell culture supernatant was detected. 50 And perform IFA testing.
[0082] Protein samples were prepared according to the method in (II). Western blot results showed that compared with cells infected with PPRV alone, the viral replication level in cells transfected with interfering RNA of Rab7 gene (i.e., siRab7) and then infected with PPRV was significantly promoted, while the viral replication level in cells transfected with NC and then infected with PPRV did not change significantly ( Figure 6 A).
[0083] Resuspend the Vero cells in the logarithmic growth phase and adjust the cell concentration to 2×10 4 / mL, evenly inoculated into 96-well plates, and when the cell density reached about 80%, gradient dilution (10 1 ~10 10) were added to a 96-well plate, and 8 replicate wells were inoculated for each gradient concentration for parallel replication. At the same time, an equal amount of maintenance solution was added to the blank control wells. The CPE was observed every day, and the viral titer of the amplified PPRV (i.e., TCID 50 ), and the virus titer in the cell culture supernatant of the PPRV-only infection group and the NC+PPRV group was detected as a control. The results showed that compared with the cells infected with PPRV alone, knocking down the expression of the Rab7 gene and then infecting PPRV could significantly increase the virus titer in the cell culture supernatant, while there was no significant change in the virus titer in the NC-transfected and then infected PPRV group ( Figure 6 B).
[0084] The cells in the siRab7+PPRV group, MOCK group, PPRV group and NC+PPRV group were fixed with 4% paraformaldehyde, permeabilized with 0.5% Triton X-100 for 10 minutes after fixation at room temperature for 30 minutes, and then blocked with 5% BSA for 1.5 hours; 1% BSA was used as an antibody diluent, Rab7 antibody was added, incubated at 4°C overnight, and the cells were washed with PBST solution; 1% BSA was used as an antibody diluent, PPRV-N antibody was added, incubated at 4°C for 8 hours, and the cells were washed with PBST solution; Cy3-labeled goat anti-rabbit fluorescent secondary antibody and AlexaFluor 488-labeled goat anti-mouse fluorescent secondary antibody were added accordingly, and incubated at 37°C in the dark for 1.5 hours; Hoechest 33342 was added to stain the nucleus for 10 minutes; the fluorescence intensity of PPRV-N protein and Rab7 protein was observed under a laser confocal microscope. The results of IFA detection of the fluorescence intensity of PPRV-N protein and Rab7 protein in cells showed that compared with the cells infected with PPRV only, the PPRV-N protein content indicated by green fluorescence in the cells infected with PPRV after transfection with Rab7 gene interfering RNA was significantly increased, and the Rab7 protein content indicated by red fluorescence in this group of cells was significantly decreased. However, there was no significant change in the green fluorescence intensity and red fluorescence intensity in the cells infected with NC and then infected with PPRV. Figure 6 C).
[0085] The above results indicate that the intracellular PPRV replication level increases with Rab7 gene knockdown expression.
[0086] (VIII) Other experimental results
[0087] After overexpressing the goat Rab7 gene in goat EECs, observation under transmission electron microscopy revealed that the number of intracellular multivesicular bodies and intraluminal vesicles was significantly reduced, resulting in a decrease in the secretion level of exosomes. This suggests that overexpression of the Rab7 gene can reduce the efficiency of cell-to-cell transmission of proliferative infection established through the PPRV exosome pathway.
[0088] In summary, the present invention has experimentally found that: (1) after using gene knockdown technology to interfere with the expression of goat Rab7 gene, as the expression of Rab7 is downregulated, the replication of PPRV is promoted, and the in vitro replication level and virus titer of PPRV are significantly increased, while after overexpressing goat Rab7 gene, as the expression of Rab7 is upregulated, the replication of PPRV is inhibited, and the in vitro replication level and virus titer of PPRV are significantly reduced, and overexpressing goat Rab7 gene can inhibit the cell-to-cell transmission efficiency of PPRV. Therefore, goat Rab7 gene is a disease-resistant gene for peste des petits ruminants, and can be used for certain antiviral (such as PPRV) applications; (2) after interfering with the expression of goat Rab7 gene, PPRV can replicate rapidly and obtain high-titer PPRV virus. Taking goat EECs as an example, the virus titer in the cell culture supernatant is 15% to 25% higher than that in the supernatant of normal infected cells, and can reach up to 10 -6.87 / 0.1mL. (3) After overexpressing the goat Rab7 gene, the corresponding Rab7 can effectively inhibit the increase in viral replication level during the replication cycle of PPRV infection. The above characteristics indicate that this disease resistance gene can be used to study the proliferation and transmission mechanism of PPR virus, thereby providing new ideas for the prevention and control of PPR, and at the same time providing efficient virus amplification cells for revealing the pathogenic mechanism of PPRV and the preparation of PPRV vaccine.
Claims
1. Use of a Rab7 gene overexpression vector in the preparation of a drug for resisting peste des petits ruminants virus, characterized in that: The expression vector includes the sheep Rab7 gene.
2. The use according to claim 1, characterized in that: The sheep Rab7 gene is from goat.
3. The use according to claim 1, characterized in that: The nucleotide sequence of the sheep Rab7 gene is shown in SEQ.ID.NO.
1.
4. The use according to claim 1, characterized in that: The expression vector is prepared by inserting the sheep Rab7 gene into the pcDNA3.1(+) vector.
5. The use according to claim 1, characterized in that: The method for preparing the expression vector comprises the following steps: 1) Taking sheep Rab7 gene as the target gene, amplifying the target gene and performing a ligation reaction with the expression vector backbone to obtain a ligation product; 2) The ligation product is transformed into a host bacterium for resistance screening, and the single clone obtained by screening is cultured after colony PCR identification. After the culture, the plasmid is extracted for verification, and the correct plasmid, namely, the Rab7 gene overexpression vector, is verified.
6. The use according to claim 1, characterized in that: The expression vector inhibits the replication of peste des petits ruminants virus.
7. The use according to claim 1, characterized in that: The expression vector inhibits the increase of virus replication level during the infection and replication cycle of peste des petits ruminants virus.
8. A method for preparing high-titer peste des petits ruminants virus, characterized in that: The following steps are involved: The siRNA interfering with the expression of sheep Rab7 gene is transfected into the host sheep cells to obtain the interfering cells; the interfering cells are infected with the peste des petits ruminants virus and then cultured, and after the culture is completed, the cell culture supernatant is separated to obtain the high titer peste des petits ruminants virus.
9. A method for preparing high-titer peste des petits ruminants virus according to claim 8, characterized in that: The nucleotide sequence of the siRNA is as follows: sense: 5'-CAACUAAUUUCCUGAACCU-3' antisense: 5'-AGGUUCAGGAAAUUCGUUG-3'.
10. A virus amplification cell, characterized in that: The cell is a host sheep cell infected with peste des petits ruminants virus and the expression of Rab7 gene is knocked down.
